ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

July 14, 2006

NIH Makes Changes To Area Grants

April 25, 1997

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979